trending Market Intelligence /marketintelligence/en/news-insights/trending/rwjpjdablvpgd_6p6x75mq2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Anteo Diagnostics extends interim CEO's appointment

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Anteo Diagnostics extends interim CEO's appointment

Anteo Diagnostics Ltd. said Christopher Parker will remain as the company's interim CEO until June 30, 2019.

In April, Parker was appointed to the interim CEO post for an initial three-month period.

The contract extension will provide business continuity as the company executes its development strategy in the battery and diagnostic markets.

Australia-based Anteo Diagnostics is engaged in the development and commercialization of products for the life sciences, clinical diagnostics and bioseparations sectors.